CN114343037A - Health tea bag for preventing pneumonia and preparation method thereof - Google Patents
Health tea bag for preventing pneumonia and preparation method thereof Download PDFInfo
- Publication number
- CN114343037A CN114343037A CN202210004759.1A CN202210004759A CN114343037A CN 114343037 A CN114343037 A CN 114343037A CN 202210004759 A CN202210004759 A CN 202210004759A CN 114343037 A CN114343037 A CN 114343037A
- Authority
- CN
- China
- Prior art keywords
- tea bag
- health
- weight portion
- preventing pneumonia
- health tea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Abstract
The invention discloses a health-care tea bag for preventing pneumonia and a preparation method thereof, and belongs to the technical field of health-care tea bag preparation. A health tea bag for preventing pneumonia is prepared from rhizoma Dioscoreae, fructus Jujubae, radix Angelicae Dahuricae, semen lablab album, flos Lonicerae, herba Taraxaci, herba Agastaches, fructus Amomi, pericarpium Citri Tangerinae, radix Platycodi and Bulbus Lilii by inspecting and accepting, weighing, drying, pulverizing, mixing and packaging.
Description
Technical Field
The invention relates to the technical field of health-care tea bag preparation, in particular to a health-care tea bag for preventing pneumonia and a preparation method thereof.
Background
Traditional Chinese medicine plays an important role in epidemic disease treatment, and particularly provides a concept of 'prevention before disease, emphasizing prevention over treatment' for the prevention of epidemic disease. The traditional Chinese medicine medicated diet drink is a preparation formulation prepared by combining selected medicines for preventing and treating diseases, conditioning after diseases or only preserving health and caring according to the principle of theory, method, formula and pharmacology theory of traditional Chinese medicine and judging the state of an illness according to the combination of syndrome differentiation, syndrome differentiation and disease differentiation. The Chinese herbal medicine is taken by brewing and decocting instead of tea, and can play the effects of building body, prolonging life and resisting attack of pathogenic factors through the combined action of multiple components, multiple ways and multiple targets. And the traditional Chinese medicine tea drink is taken as the traditional formulation in China, has the characteristics of simplicity, convenience and high efficiency, is very wide in clinical application, is accepted and loved by more and more people, and plays an important role in the medical care industry.
The novel preventive medicine for coronavirus pneumonia in the prior art is mainly a product for tonifying qi and spleen, eliminating dampness and clearing heat, comprises tea drink prepared from astragalus, honeysuckle, liquorice, patchouli, platycodon grandiflorum, dried orange peel, divaricate saposhnikovia root, bighead atractylodes rhizome, rhizoma atractylodis and other high-frequency medicines, has poor prevention and treatment and health-care effects on pneumonia caused by dampness, heat and toxicity, and is bitter and astringent in drinking taste and low in acceptance.
Disclosure of Invention
1. Technical problem to be solved
Aiming at the problems in the prior art, the invention aims to provide a health-care tea bag for preventing pneumonia and a preparation method thereof, and the health-care tea bag has good prevention, treatment and health-care effects on pneumonia caused by dampness, heat and toxicity.
2. Technical scheme
In order to solve the above problems, the present invention adopts the following technical solutions.
A health tea bag for preventing pneumonia comprises the following components in parts by weight: 3-15g of Chinese yam, 2-12g of Chinese date, 2.5-10g of angelica dahurica, 1.4-11.2g of white hyacinth bean, 4.2-10.5g of honeysuckle, 4.5-11.8 g of dandelion, 5-10g of wrinkled gianthyssop herb, 5.2-9.6g of fructus amomi, 4-8g of dried orange peel, 7-10g of platycodon grandiflorum and 8-12g of lily;
the preparation method comprises the following steps: the method comprises the following steps:
step one, checking and accepting raw materials;
weighing, namely weighing the components according to the component ratio;
drying, namely drying the Chinese yam, the Chinese date, the angelica dahurica, the white hyacinth bean, the honeysuckle, the dandelion, the agastache rugosus, the fructus amomi, the dried orange peel, the platycodon grandiflorum and the lily respectively;
step four, crushing, namely respectively crushing Chinese yam, Chinese date, angelica dahurica, white hyacinth bean, honeysuckle, dandelion, agastache rugosus, fructus amomi, dried orange peel, platycodon grandiflorum and lily to obtain crushed materials;
step five, mixing materials, namely uniformly mixing the crushed materials of the Chinese yam, the Chinese date, the angelica dahurica, the white hyacinth bean, the honeysuckle, the dandelion, the agastache rugosus, the fructus amomi, the dried orange peel, the platycodon grandiflorum and the lily obtained in the step three to obtain a mixture;
and step six, packaging, namely quantitatively bagging the mixture obtained in the step four in a sterile environment, and sealing to obtain the health-care tea bag.
Further, the weight portion of the Chinese yam is 10 g; the weight portion of the Chinese date is 10 g; the weight part of the angelica dahurica is 10 g; the weight portion of the white hyacinth beans is 10 g; the weight portion of the honeysuckle is 10 g; the weight portion of the dandelion is 10 g; 10g of wrinkled gianthyssop herb; 10g of fructus amomi; the weight portion of the dried orange peel is 10 g; the weight portion of the platycodon root is 10 g; the weight portion of the lily is 10 g.
Further comprises 5-8g of liquorice.
Further, the yam, the Chinese date, the angelica dahurica, the white hyacinth bean, the honeysuckle, the dandelion, the agastache, the fructus amomi, the dried orange peel, the platycodon grandiflorum and the lily are respectively crushed into non-powder state, and the particle size of the crushed materials is 0.1cm-4 cm.
Further, adding one or more of the crushed materials of rose, jasmine, sweet osmanthus, hawthorn and chrysanthemum morifolium into the mixture obtained in the fifth step, and uniformly mixing.
Further, the weight of the health-care tea bag obtained in the step six is 120 g.
Further, when the health-care tea bag obtained in the sixth step is brewed, the weight ratio of the health-care tea bag to the aqueous solution is 1: 60-100.
Further, the health tea bag has a shelf life of twelve months, is stored in a shady and cool sealed environment, and is refrigerated after being unsealed.
3. Advantageous effects
Compared with the prior art, the invention has the advantages that:
(1) the scheme can have better prevention and treatment and health care effects on pneumonia caused by dampness, heat and toxicity.
Drawings
FIG. 1 is a principal flow diagram of the present invention;
fig. 2 is a schematic comparison diagram between the health tea bag according to the first embodiment of the present invention and the health tea bags prepared according to the formulas 1 and 2;
FIG. 3 is a table of taste profiles of the present invention;
FIG. 4 is a graph showing the effect of tea drink of the present invention on the expression of positive cells of TLR4 protein in lung tissue of mice infected with Pseudomonas aeruginosa;
FIG. 5 is a graph showing the effect of tea drink of the present invention on the expression of positive cells of CXCR4 protein in lung tissue of mice infected with Pseudomonas aeruginosa;
FIG. 6 is a graph showing the effect of tea drink of the present invention on TNF-. alpha.mRNA expression in THP-1 cells;
FIG. 7 is a graph showing the effect of tea drink of the present invention on the expression of IL-6mRNA in THP-1 cells.
Detailed Description
Example (b):
referring to fig. 1 to 7, a health tea bag for preventing pneumonia comprises the following components in parts by weight: 3-15g of Chinese yam, 2-12g of Chinese date, 2.5-10g of angelica dahurica, 1.4-11.2g of white hyacinth bean, 4.2-10.5g of honeysuckle, 4.5-11.8 g of dandelion, 5-10g of wrinkled gianthyssop herb, 5.2-9.6g of fructus amomi, 4-8g of dried orange peel, 7-10g of platycodon grandiflorum and 8-12g of lily;
the preparation method comprises the following steps: the method comprises the following steps:
step one, checking and accepting raw materials;
weighing, namely weighing the components according to the component ratio;
drying, namely drying the Chinese yam, the Chinese date, the angelica dahurica, the white hyacinth bean, the honeysuckle, the dandelion, the agastache rugosus, the fructus amomi, the dried orange peel, the platycodon grandiflorum and the lily respectively;
step four, crushing, namely respectively crushing Chinese yam, Chinese date, angelica dahurica, white hyacinth bean, honeysuckle, dandelion, agastache rugosus, fructus amomi, dried orange peel, platycodon grandiflorum and lily to obtain crushed materials;
step five, mixing materials, namely uniformly mixing the crushed materials of the Chinese yam, the Chinese date, the angelica dahurica, the white hyacinth bean, the honeysuckle, the dandelion, the agastache rugosus, the fructus amomi, the dried orange peel, the platycodon grandiflorum and the lily obtained in the step three to obtain a mixture;
and step six, packaging, namely quantitatively bagging the mixture obtained in the step four in a sterile environment, and sealing to obtain the health-care tea bag.
The Chinese yam is a good product entering lung, can keep blood vessel elasticity and has the efficacy of building body.
The Chinese date can neutralize the bitter taste of the health tea bag when drinking, so that the Chinese date can be more acceptable to drinkers when drinking.
The angelica dahurica has the effects of dispelling cold, relieving exterior syndrome, reducing swelling and expelling pus, and the coumarin contained in the angelica dahurica has obvious effects of clearing heat, relieving pain and resisting inflammation.
The white hyacinth bean has the effects of eliminating dampness and tonifying spleen.
The flos Lonicerae has antibacterial, antiviral, antiinflammatory, antipyretic, and phagocytic percentage and phagocytic index increasing effects.
Herba Agastaches has analgesic, dampness eliminating, turbid pathogen removing, antifungal and antiviral effects.
The fructus amomi has the effects of resolving dampness, stimulating appetite, warming spleen and stopping diarrhea, so that the appetite is better and the moisture is effectively removed after the health-care tea bag beverage is drunk.
The pericarpium Citri Tangerinae has effects of resisting oxidation, tonifying heart, and inhibiting bacteria.
Radix Platycodi has effects of tranquilizing, relieving pain, relieving fever, and resisting inflammation.
Bulbus Lilii has antibacterial, antiinflammatory, and immunity enhancing effects.
In the fourth step, rhizoma Dioscoreae, fructus Jujubae, radix Angelicae Dahuricae, semen lablab album, flos Lonicerae, herba Taraxaci, herba Agastaches, fructus Amomi, pericarpium Citri Tangerinae, radix Platycodi and Bulbus Lilii are respectively pulverized into non-powder state, and the particle size of the pulverized material is 0.1cm-4 cm.
And D, adding one or more of the crushed substances of rose, jasmine, sweet osmanthus, hawthorn and chrysanthemum morifolium into the mixture obtained in the step five, and uniformly mixing.
Experiments show that the health-care tea bags prepared by adding rose, jasmine, sweet osmanthus, hawthorn and chrysanthemum into the mixture respectively are invited to people of different age groups to taste, so that the taste ranking is obtained, the chrysanthemum is larger than the jasmine, the jasmine is larger than the hawthorn, the hawthorn is larger than the rose, and the rose is larger than the sweet osmanthus, so that the crushed material added into the mixture is preferably chrysanthemum, the traditional Chinese medicine taste of the health-care tea bags after being brewed can be reduced after the chrysanthemum is added, and the taste is better.
The weight of the health-care tea bag obtained in the sixth step is 100-120 g.
And when the health-care tea bag obtained in the sixth step is brewed, the weight ratio of the health-care tea bag to the aqueous solution is 1: 60-100.
The weight portion of the Chinese yam is 10 g; the weight portion of the Chinese date is 10 g; the weight part of the angelica dahurica is 10 g; the weight portion of the white hyacinth beans is 10 g; the weight portion of the honeysuckle is 10 g; the weight portion of the dandelion is 10 g; 10g of wrinkled gianthyssop herb; 10g of fructus amomi; the weight portion of the dried orange peel is 10 g; the weight portion of the platycodon root is 10 g; the weight portion of the lily is 10 g.
When the health-care tea bag is actually made, the weight of the formula can be proportionally reduced to the weight suitable for production so as to be matched with the size of the health-care tea bag on the market.
The drinking method of the health tea bag is that the later generation tea is drunk after being boiled by adding water every day, and the tea is frequently drunk for no time limit; the brewing temperature is 70-100 deg.C, specifically 80 deg.C or 90 deg.C; after the health-care tea bag is brewed, the health-care tea bag is kept stand to be better in drinking taste at normal temperature, and the drinking taste at high temperature is more normal in temperature difference; the health tea bag has a shelf life of twelve months, and can be stored in a cool and sealed environment, and then refrigerated after being unsealed.
Example 2:
the weight portion of the Chinese yam is 5 g; the weight portion of the Chinese date is 5 g; the weight part of the angelica dahurica is 5 g; the weight portion of the white hyacinth beans is 5 g; the weight portion of the honeysuckle is 5 g; the weight portion of the dandelion is 5 g; the weight portion of the ageratum is 5 g; the weight part of the amomum villosum is 5 g; the weight portion of the dried orange peel is 5 g; the weight portion of the platycodon grandiflorum is 5 g; the weight portion of the raw licorice is 3 g; the weight portion of the lily is 5 g.
Example 3:
the liquorice tea bag further comprises 5-8g of liquorice, particularly 6g of liquorice, the bitter taste of the finally prepared health-care tea bag during drinking can be neutralized through the addition of the liquorice, the mouthfeel is improved, and the mouthfeel of the health-care tea bag during drinking is further improved by matching with the Chinese date.
Example 4:
the folium artemisiae argyi is added on the basis of the formula of the embodiment 1 or 2, so that the folium artemisiae argyi has antibacterial and antiviral effects, the occurrence of cell inflammation and apoptosis can be inhibited, the immunity is improved, and pneumonia can be better prevented after the health tea bag beverage is drunk.
In order to prove that the health tea bags prepared according to the formula in example 1 or example 2 are better health tea bags suitable for preventing pneumonia, two groups of comparative tests are carried out, and refer to fig. 2:
the first group is formula 1, 10g of wrinkled gianthyssop herb, 10g of Chinese mosla herb, 10g of ginkgo seed, 10g of kelp, 10g of mint, 10g of lily, 10g of Chinese yam, 10g of Chinese date, 10g of white hyacinth bean, 6g of safflower, 15g of reed rhizome, 10g of raw liquorice and 6g of red yeast rice, and the finally prepared health-care tea bag has the effects of regulating qi, tonifying qi and nourishing yin and is suitable for common Xinguan patients.
The second group is formula 2, 10g of wrinkled gianthyssop herb, 10g of Chinese mosla herb, 10g of ginkgo seed, 10g of kelp, 10g of mint, 10g of lily, 10g of Chinese yam, 10g of Chinese date, 10g of white hyacinth bean, 6g of safflower, 15g of reed rhizome, 10g of raw liquorice, 6g of red yeast rice, 6g of peach kernel, 30g of fried pearl barley and 10g of houttuynia cordata, and the finally prepared health-care tea bag has the effects of regulating qi activity, tonifying qi and yin, promoting blood circulation and removing blood stasis and is suitable for patients with pulmonary fibrosis in the convalescence.
The formula of the health-care tea bag is formula 3, and the prepared health-care tea bag has the effects of tonifying qi, invigorating spleen and promoting diuresis, is suitable for prevention of common people and has wider applicability.
Fig. 3 is a table showing the taste identification of the health tea bag brewed beverages prepared according to the formulas 1, 2 and 3, and it can be seen that the drinker has a higher taste acceptance of the formula 3.
In order to further verify that the formula 3 has the effectiveness of improving immunity, improving lung function and the like, relevant immune indexes, inflammatory factors and lung tissues are detected by intervening an animal model through the formula, and experimental results are observed, wherein the specific experimental process is as follows:
animal grouping, pre-modeling intervention, modeling and drug delivery
Randomly dividing 60 BABL/c mice with the age of 8 weeks into a normal group, a model group and a blank control group, and dividing the formula 3 tea drink into an early intervention group, a later intervention group and a whole-course intervention group, wherein each group contains 10 mice; except the normal group, the other groups are injected with pseudomonas aeruginosa in the trachea to establish a pneumonia model.
The early stage of the drying and pre-forming is started 10 days before the molding and the stomach filling of the health care tea is started, and the drying and pre-forming is stopped when the molding is performed; after the molding is successfully performed, the later-stage intervention group starts intragastric administration until the experiment is finished; the whole-course intervention group adopts the health-care tea for intragastric administration continuously from the beginning to the end of the experiment; the normal group and the model group both adopt the same volume of physiological saline for intragastric administration and contrast; and observing and recording the weight and the breath change per minute of the mice before and after the model building and before and after the health-care tea drying.
During the experiment, diet and drinking water are monitored by videos every day for 24 hours for playback in the future; changes in body weight were recorded daily, fresh mouse faeces were collected daily (-80 ℃ storage), during which time there were deaths, and the date, body weight and pre-death clinical presentation were recorded in detail.
Second, animal specimen collection and treatment
After the experiment is finished, obtaining bronchoalveolar lavage fluid of a mouse, after the mouse is killed by ether anesthesia, taking blood from heart, dividing the blood sample into two parts, carrying out anticoagulation treatment on one part (0.4ml), centrifuging the other part to obtain a serum sample, and preserving at-80 ℃; after the experiment is finished, collecting lung, spleen, lymph tissue, intestinal tract and contents thereof of the mouse, taking a proper amount of lung, spleen and small intestine or colon tissue, fixing the lung, spleen and small intestine or colon tissue in 4% paraformaldehyde solution, then using the tissue for later stage pathological examination, quickly freezing the rest tissues by liquid nitrogen, and transferring the tissue to-80 ℃ for storage.
The immunohistochemical method is used for determining the expression level of TLR4 and CXCR4 proteins in lung tissues and the distribution condition in tissues to judge the pathological condition of the lung:
mouse lung tissue immunohistochemistry and semi-quantitative analysis: marking the lung tissue section, inserting the lung tissue section into a staining rack, and dewaxing to water; placing the slicing frame in deionized water for 5min, adding into antigen repairing solution, and placing into micro-lensCooling naturally for 7min, taking out, washing with phosphate buffer solution for 5min × 3 times, and washing with 3% H2O2Blocking endogenous peroxidase with deionized water for 20min, and washing with PBS for 5min × 3 times; sealing biological serum for 40min, and spin-drying without washing; incubating the prepared primary antibody by 30 mu l, washing by 5min multiplied by 3 times after PBS rapidly washes by 1 time, incubating by 20min for the secondary antibody by 30 mu l, washing by 5min multiplied by 3 times after PBS rapidly washes by 1 time; incubating horseradish peroxidase 30 μ l for 20min, washing with PBS for 5min × 3 times; performing color development by using DAB color development liquid, putting the DAB color development liquid into hematoxylin solution for counterstaining for 2min, and then performing blue returning by using tap water; xylene transparent, neutral resin sealing; observing each group of slices under a microscope and taking pictures; TLR4 positive staining was tan to tan, since TLR4 was mainly expressed in the cytoplasm of inflammatory cells, alveolar epithelial cells, fibroblasts, etc., and alveolar cytoplasm and/or cell membrane, semi-quantitative analysis was performed using Imageproplus software using mean optical density values; CXCR4 positive staining is tan to tan and is generally expressed on alveolar epithelial cells and on the cytoplasm and cell membranes in the alveolar mesenchyme, so the AB value quantitative scoring method is adopted according to the literature.
The real-time fluorescent quantitative PCR technology is used for measuring the expression quantity of IL-6 and TNF-alpha mRNA in the cells:
selecting and dividing THP-1 cells after passage into blank group, control group and drug-adding group, dividing all groups into three multiple wells, adding 20 μ l culture medium into the blank group, adding 20 μ l filtered drug (125 μmolL) into the drug-adding group-1) Terminating the culture after 24 hours; then adding 800 mu L Trizol into the cell culture hole, and then sequentially adding cell lysate chloroform, isopropanol and 75% alcohol to extract total RNA; dissolving RNA in deionized water added with DEPC (diethyl pyrocarbonate), then measuring the purity and concentration of A260 and A280 quantitative analysis RNA by using an ultraviolet spectrophotometer, and further performing reverse transcription to form cDNA according to the total RNA concentration and a reverse transcription kit, wherein the reaction conditions are as follows: annealing at 25 deg.C for 5 min; extending at 42 ℃ for 60 min; inactivating at 70 deg.C for 5 min.
The fluorescent quantitative PCR primers for detection are as follows:
the qPCR reaction system comprises 10 mu L of SYBR Green Premix Ex Taq II, 1.6 mu L of forward and reverse primers (5 pmol/. mu.L), and ddH2O4.8. mu.L and cDNA 2. mu.L; the reaction conditions are pre-denaturation at 95 ℃ for 30s, denaturation at 95 ℃ for 5s, 60 ℃ for 30s and cycle number of 40; dissolution curve: 95 ℃, 15s, 60 ℃, 30s, 95 ℃, 15 s. And (5) correcting the Ct value of each sample by taking GAPDH as an internal reference in detection to obtain a delta Ct value.
SPSS25.0 statistical software is adopted for processing, data measurement values are expressed by mean +/-standard deviation (x +/-s), homogeneity of variance is firstly tested before each group of data are compared, single-factor variance analysis is adopted when normal distribution and homogeneity of variance are met, independent sample t test is adopted for mean comparison between two groups of samples, and the difference is considered to have statistical significance when P is less than 0.05.
Fig. 4 is a graph showing the effect of tea drink of the present invention on the expression of the TLR4 protein positive cells in lung tissue of mice infected with pseudomonas aeruginosa (immunohistochemistry, x 200), wherein the graph shows from left to right: A. blank group; B. a model group; C. a model control group; D. early intervention group; E. a later intervention group; F. and (4) performing whole-process intervention group.
Fig. 5 is a graph showing the effect of tea drink of the present invention on the expression of CXCR4 protein positive cells in lung tissue of mice infected with pseudomonas aeruginosa (immunohistochemistry, x 200), from left to right: A. blank group; B. a model group; C. a model control group; D. early intervention group; E. a later intervention group; F. and (4) performing whole-process intervention group.
The results in FIG. 6 and FIG. 7 show that the blank group and the control group have no significant difference in the expression level of TNF-alpha mRNA in the THP-1 cells; however, the expression level of IL-6mRNA was decreased in the tea drink-treated group (MCD group), i.e., the tea-treated group treated with Yi Yang tea, compared with the blank and the control group, and the difference was statistically significant (P < 0.05).
The research results show that the tea drink group has low observation score of lung pathological tissues, the expression of TLR4 and CXCR4 proteins is low, the influence on congestion and edema of mouse lung tissues, lung structural damage and fiber mass formation is obviously reduced compared with a model group and a control group, and the research results show that the tea drink can effectively prevent and treat the mouse lung damage caused by LPS (lipopolysaccharide), and the treatment effect on the lung damage is achieved by mainly inhibiting TLR4 and CXCR4 signal channels to play a role in anti-inflammatory response.
Sequence listing
<110> Luwenliang
<120> a health tea bag for preventing pneumonia and a preparation method thereof
<141> 2022-01-04
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 23
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
ggctgtatat ctgctctata tgc 23
<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
ccgcttcctt tgtccatcag 20
<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
atcttctgta cagtcaagtc c 21
<210> 4
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
gctttcctca tggaagggat a 21
Claims (8)
1. A health tea bag for preventing pneumonia is characterized in that: the paint comprises the following components in parts by weight: 3-15g of Chinese yam, 2-12g of Chinese date, 2.5-10g of angelica dahurica, 1.4-11.2g of white hyacinth bean, 4.2-10.5g of honeysuckle, 4.5-11.8 g of dandelion, 5-10g of wrinkled gianthyssop herb, 5.2-9.6g of fructus amomi, 4-8g of dried orange peel, 7-10g of platycodon grandiflorum and 8-12g of lily;
the preparation method comprises the following steps: the method comprises the following steps:
step one, checking and accepting raw materials;
weighing, namely weighing the components according to the component ratio;
drying, namely drying the Chinese yam, the Chinese date, the angelica dahurica, the white hyacinth bean, the honeysuckle, the dandelion, the agastache rugosus, the fructus amomi, the dried orange peel, the platycodon grandiflorum and the lily respectively;
step four, crushing, namely respectively crushing Chinese yam, Chinese date, angelica dahurica, white hyacinth bean, honeysuckle, dandelion, agastache rugosus, fructus amomi, dried orange peel, platycodon grandiflorum and lily to obtain crushed materials;
step five, mixing materials, namely uniformly mixing the crushed materials of the Chinese yam, the Chinese date, the angelica dahurica, the white hyacinth bean, the honeysuckle, the dandelion, the agastache rugosus, the fructus amomi, the dried orange peel, the platycodon grandiflorum and the lily obtained in the step three to obtain a mixture;
and step six, packaging, namely quantitatively bagging the mixture obtained in the step four in a sterile environment, and sealing to obtain the health-care tea bag.
2. The health tea bag for preventing pneumonia according to claim 1, wherein: the weight portion of the Chinese yam is 10 g; the weight portion of the Chinese date is 10 g; the weight part of the angelica dahurica is 10 g; the weight portion of the white hyacinth beans is 10 g; the weight portion of the honeysuckle is 10 g; the weight portion of the dandelion is 10 g; 10g of wrinkled gianthyssop herb; 10g of fructus amomi; the weight portion of the dried orange peel is 10 g; the weight portion of the platycodon root is 10 g; the weight portion of the lily is 10 g.
3. The health tea bag for preventing pneumonia according to claim 1, wherein: also comprises 5-8g of liquorice.
4. The health tea bag for preventing pneumonia according to claim 1, wherein: in the fourth step, rhizoma Dioscoreae, fructus Jujubae, radix Angelicae Dahuricae, semen lablab album, flos Lonicerae, herba Taraxaci, herba Agastaches, fructus Amomi, pericarpium Citri Tangerinae, radix Platycodi and Bulbus Lilii are respectively pulverized into non-powder state, and the particle size of the pulverized material is 0.1cm-4 cm.
5. The health tea bag for preventing pneumonia according to claim 1, wherein: and D, adding one or more of the crushed substances of rose, jasmine, sweet osmanthus, hawthorn and chrysanthemum morifolium into the mixture obtained in the step five, and uniformly mixing.
6. The health tea bag for preventing pneumonia according to claim 1, wherein: the weight of the health-care tea bag obtained in the sixth step is 100-120 g.
7. The health tea bag for preventing pneumonia according to claim 1, wherein: and when the health-care tea bag obtained in the sixth step is brewed, the weight ratio of the health-care tea bag to the aqueous solution is 1: 60-100.
8. The health tea bag for preventing pneumonia according to claim 1, wherein: the health tea bag has a shelf life of twelve months, and can be stored in a cool and sealed environment, and then refrigerated after being unsealed.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210004759.1A CN114343037A (en) | 2022-01-04 | 2022-01-04 | Health tea bag for preventing pneumonia and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210004759.1A CN114343037A (en) | 2022-01-04 | 2022-01-04 | Health tea bag for preventing pneumonia and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114343037A true CN114343037A (en) | 2022-04-15 |
Family
ID=81106485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210004759.1A Pending CN114343037A (en) | 2022-01-04 | 2022-01-04 | Health tea bag for preventing pneumonia and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114343037A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105998821A (en) * | 2016-07-04 | 2016-10-12 | 山西省中医药研究院 | Traditional Chinese medicine preparation for preventing and treating yin deficiency and lung heat radiation-induced lung injury and preparation method of traditional Chinese medicine preparation |
| US20180085416A1 (en) * | 2016-09-27 | 2018-03-29 | Infinitus (China) Company Ltd. | Traditional chinese medicine composition and preparation method and use thereof |
| CN108210866A (en) * | 2018-01-12 | 2018-06-29 | 云南滇药医药健康产业有限公司 | Composition with invigorating the spleen to clear away damp pathogen effect and preparation method thereof |
| CN109480028A (en) * | 2019-01-01 | 2019-03-19 | 孟九任 | A kind of prebiotic tea and preparation method thereof |
| CN110100940A (en) * | 2019-06-20 | 2019-08-09 | 珠海林尚熙养生茶业有限公司 | A kind of invigorating the spleen to clear away damp pathogen tea and preparation method thereof |
| CN112914097A (en) * | 2019-12-06 | 2021-06-08 | 神威药业集团有限公司 | Health-care solid beverage for damp-heat constitution and preparation method thereof |
| CN113142349A (en) * | 2020-04-03 | 2021-07-23 | 黄璐琦 | Novel bagged tea for preventing coronavirus pneumonia and preparation method thereof |
-
2022
- 2022-01-04 CN CN202210004759.1A patent/CN114343037A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105998821A (en) * | 2016-07-04 | 2016-10-12 | 山西省中医药研究院 | Traditional Chinese medicine preparation for preventing and treating yin deficiency and lung heat radiation-induced lung injury and preparation method of traditional Chinese medicine preparation |
| US20180085416A1 (en) * | 2016-09-27 | 2018-03-29 | Infinitus (China) Company Ltd. | Traditional chinese medicine composition and preparation method and use thereof |
| CN108210866A (en) * | 2018-01-12 | 2018-06-29 | 云南滇药医药健康产业有限公司 | Composition with invigorating the spleen to clear away damp pathogen effect and preparation method thereof |
| CN109480028A (en) * | 2019-01-01 | 2019-03-19 | 孟九任 | A kind of prebiotic tea and preparation method thereof |
| CN110100940A (en) * | 2019-06-20 | 2019-08-09 | 珠海林尚熙养生茶业有限公司 | A kind of invigorating the spleen to clear away damp pathogen tea and preparation method thereof |
| CN112914097A (en) * | 2019-12-06 | 2021-06-08 | 神威药业集团有限公司 | Health-care solid beverage for damp-heat constitution and preparation method thereof |
| CN113142349A (en) * | 2020-04-03 | 2021-07-23 | 黄璐琦 | Novel bagged tea for preventing coronavirus pneumonia and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 张涵灵等: "浅析中药代茶饮在新型冠状病毒肺炎预防中的用药规律", 湖北中医药大学学报, vol. 22, no. 5, pages 45 - 49 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chen et al. | Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis | |
| CN102488798B (en) | Medicine for treating non-alcoholic fatty liver | |
| CN111991484A (en) | A pharmaceutical composition for treating respiratory diseases in winter | |
| CN102641395A (en) | Medicament composite for treating constipation as well as preparation method and application of medicament composite | |
| CN105056128B (en) | A kind of Chinese medicine composition and preparation method and application for treating atrophic gastritis and intestines | |
| CN111920882A (en) | A pharmaceutical composition for treating respiratory diseases in summer | |
| CN103341092A (en) | Preparation method of powder for treating atrophic vaginitis | |
| CN114343037A (en) | Health tea bag for preventing pneumonia and preparation method thereof | |
| CN102188682A (en) | Chinese medicinal composition for treating biliary calculus and preparation method thereof | |
| WO2021169682A1 (en) | Traditional chinese medicine composition, and preparation method therefor and application thereof | |
| CN107029074A (en) | A kind of pharmaceutical composition and preparation method and purposes for treating fatty liver | |
| CN104056242A (en) | Traditional Chinese medicine composition for treating acute cholecystitis and preparation method thereof | |
| CN105327115A (en) | Phellinus linteus catharsis formula for prevention and cure of type II diabetes and preparation process thereof | |
| CN105327267A (en) | Traditional Chinese medicine liquor for treating tumors and preparation method of traditional Chinese medicine liquor for treating tumors | |
| CN104888121A (en) | Traditional Chinese medicine extract for adjuvant therapy of pelvic inflammation, preparation method and application of traditional Chinese medicine extract, and body cream | |
| CN110974903A (en) | Composition helpful for enhancing immunity and preparation method thereof | |
| CN103735906A (en) | Chinese herb preparation for treating dry bronchiectasis and preparation method thereof | |
| CN105617319A (en) | Preparation method of traditional Chinese medicine composition for treating acute cholecystitis | |
| CN104645247B (en) | A kind of Chinese medicine preparation for treating hepatolenticular degeneration and preparation method thereof | |
| CN115869358B (en) | Traditional Chinese medicine composition for treating non-alcoholic fatty liver disease and application thereof | |
| CN117180340B (en) | Composition for reducing blood fat and preparation method and application thereof | |
| CN108159204A (en) | A kind of Tibetan medicinal composition with removing toxic substances hepatoprotective effect | |
| CN105412609A (en) | Traditional Chinese medicine for treating hepatic stagnation and spleen deficiency type ulcerative colitis and preparation method | |
| CN104208291A (en) | Chinese medicine preparation for treating heat strangury and preparation method thereof | |
| CN105748669B (en) | Traditional Chinese medicine composition for preventing and treating alcoholic fatty liver |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |